Rumi Viro’s platform generates actionable data using phenotypic screens and the industry’s most-advanced standardized organoid platforms, to help our collaborators and partners find therapeutics.
Rumi Viro can utilize our human pluripotent stem cell-based platform on your behalf: including discovery of phenotypes and HTS through to hit validation and efficacy assessments in secondary assays, our scientists will work with your team to design your ideal project using our standardized models.
Using our deep in-house scientific expertise and our proprietary algorithms, we generate precise and usable data to your team.
Rumi Viro’s scientists can work with your drug development team on specific classes of molecules, and can generate data from our platform to support your hypothesis in re-routing of existing molecules for a new indication.
Rumi Viro can provide data to rank your compound options.
Rumi Viro can quantify efficacy & toxicity of compounds in development in order to help you with a Go/No Go decision.
Rumi Viro has the expertise and flexibility, and is interested in helping you take your program further and faster. We are always interested in discussing partnerships and licensing possibilities.